They are supporting the advance of scientific and pharmaceutical drug development to protect us against potential health threats, whether from bacterial infections or viral sources like influenza.
To date, the CDC has not found any incidence of Influenza A or B resistance to the two main anti-viral medications given to patients within the first 48 hours of infection: oseltamivir and zanamivir.